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Introduction 
Bioactive glasses (BG) have the ability to bond directly with living tissue via 
the formation of a hydroxycarbonate apatite-like layer on their surface, and are 
therefore utilised in a variety of dental and orthopaedic applications [1, 2]. However, 
this is not their only mechanism of action. BG can also be designed to release ions 
that stimulate specific cell behaviour. Indeed, we have recently reported on BG that 
release strontium ions, the active component of the osteoporosis drug strontium 
ranelate, which act to both promote osteoblast activity and inhibit osteoclast activity 
[3].  
Fluoride is widely recognised for its ability to prevent dental caries as it 
inhibits dentine and enamel demineralisation [4], however, it also affects the axial 
skeleton. That is, clinical examinations of osteoporotic patients have demonstrated 
that fluoride treatment stimulates bone formation [5]. Nevertheless, in placebo-
controlled, double-blind clinical trials, sodium fluoride (NaF) was found not to be 
efficacious in preventing osteoporosis-related fractures [6, 7]. In subsequent detailed 
analyses of these trials, fluoride’s lack of efficacy was attributed to its substitution 
into bone apatite, creating structurally and mechanically inferior bone, as mineral 
crystal size and crystallinity increased [8]. Consequently, fluoride’s use as an 
osteoporosis treatment was largely dismissed. Moreover, this seemed judicious as 
osteomalacia was reported in patients treated with NaF [9], and skeletal fluorosis, 
which is endemic in areas with high levels of fluoride in the ground water, is known 
to cause a range of skeletal abnormalities [10].  
As clinical trials with fluoride failed to demonstrate clear anti-fracture 
efficacy, other osteoporosis drugs have come into favour. Anti-catabolic agents such 
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as bisphosphonates, which block osteoclast-mediated bone resorption via inhibition of 
the mevalonate pathway [11] are widely prescribed. However, anti-catabolic agents 
only prevent further bone resorption and do not promote bone formation. 
Furthermore, long-term bisphosphonate use has been associated with osteonecrosis of 
the jaw [12] and atypical, low-energy femur fractures [13], which has created 
reluctance among some clinicians to prescribe them. Anabolic agents such as 
recombinant parathyroid hormone (PTH), which stimulate osteoblast-mediated bone 
matrix formation [14], are also often administered. However, PTH is expensive and 
requires daily subcutaneous injections. As a result, alternative treatments, such as 
inexpensive NaF, have recently been re-examined [15].  
In vitro studies point towards a small dosing range for NaF that will 
successfully promote osteoblast activity [16], and recent meta-analyses have shown 
that fluoride is efficacious in preventing osteoporosis-related fractures when 
administered at doses lower than those used in the widely reported clinical trials [17]. 
Furthermore, in vitro studies have demonstrated that fluoride has an anabolic effect on 
bone, enhancing osteoblast proliferation [18, 19] and alkaline phosphatase activity 
[19-21]. The effect, however, seems to be strongest on osteoblast precursors as 
opposed to mature cells [22, 23], suggesting that fluoride may promote osteoblast 
differentiation or maturation. Moreover, cells isolated from animals administered 
fluoride in vivo showed higher proliferative potential than those isolated and 
subsequently treated in vitro [24]. Taken together, these data suggest the importance 
of the timing of the administration of fluoride, and support a role for short-term 
treatment of less mature cells as a route for gaining the greatest benefit. Therefore, 
therapies such as BG that have the potential to locally administer therapeutic doses of 
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fluoride over a predictable time frame, may be useful for stimulating new bone 
formation. 
One important factor in designing BG is network connectivity (NC), a 
measure of the number of bridging oxygen atoms per network forming element, and 
an indicator of BG solubility, reactivity and bioactivity [25]. Here, by holding the 
ratio of network former to network modifier constant whilst adding CaF2, we created 
a BG series with increasing amounts of fluoride, but with constant NC (assuming 
fluoride only associates with calcium, i.e. Si-F bonds are not formed [26]). This 
allowed us to examine the effects of fluoride in BG on human osteoblast cells in vitro 
without complications caused by changes in the silicate network structure. We also 
separated the effects of ions released from BG from the effects elicited by cells’ 
complex interactions with the apatite-forming BG surface and examined how both 
factors influenced human osteoblast activity.  
 
Materials and Methods 
Preparation of BG discs 
BG in the system SiO2–P2O5–CaO–Na2O were prepared by a melt–quench 
route. CaF2 was added whilst NC and the ratio of all other components were kept 
constant (Table 1). Mixtures of analytical grade SiO2 (Prince Minerals Ltd., Stoke-on-
Trent, UK), P2O5, CaCO3, Na2CO3 and CaF2 (all Sigma-Aldrich, Gillingham, UK) 
were melted in a platinum-rhodium crucible for 1 h at 1430°C. A batch size of 100 g 
was used. After melting, BG were rapidly quenched in deionised water (dH2O) to 
prevent crystallisation. BG rods were produced by casting the melt into pre-heated 
graphite moulds (10 mm diameter) and subsequently annealing at the glass transition 
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temperature, which varied between 514 and 439°C [27]. Rods were sectioned into 
1 mm thick discs on a low-speed diamond saw (IsoMet®, Buehler GmbH, Düsseldorf, 
Germany) using isopropanol as a coolant. Prior to cell culture experiments, BG discs 
were sterilised under UV light for 2 h on each side and pre-conditioned in 1 mL of 
culture medium (RPMI 1640 with 1X penicillin/streptomycin solution; Invitrogen, 
Paisley, UK) for 4 days. Cell culture medium was exchanged daily and stored at -20 
°C.  
Elemental analysis of ions released from BG  
Culture medium samples were diluted by a factor of 10 in dH2O, and 
concentrations of calcium and silicon were measured on an inductively coupled 
plasma – optical emission spectrometer (ICP-OES) (iCAP 6000, Thermo Scientific, 
Waltham, MA, USA). Fluoride concentration was measured using a fluoride-selective 
electrode (Orion 9609BNWP with Orion pH/ISE meter 710; Thermo Scientific). 
Calibration was performed using standard solutions prepared using either dH2O or tris 
buffer for ICP-OES and fluoride measurements, respectively.  
Cell culture with BG discs 
The human osteosarcoma cell line, Saos-2, was obtained from the European 
Collection of Cell Cultures (Salisbury, UK) and cultured under standard conditions 
(37 °C, 5% CO2/95% air, 100% humidity) in RPMI 1640 with 10% (v/v) foetal 
bovine serum (FBS) and 2 mM L-glutamine (all from Invitrogen). One BG disc per 
well was seeded at 30,000 cells/cm2. The surrounding tissue culture plastic was 
likewise seeded at 30,000 cells/cm2 to assess both the effects of culture in contact 
with the BG and that resulting from exposure to their dissolution products, as 
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previously described [28]. The culture medium was exchanged 3 times per week and 
stored at -20 °C.  Discs were moved to fresh wells prior to assays to allow separate 
analyses of cells cultured in contact with discs from those only exposed to their 
dissolution products. 
For experiments with NaF, 30,000 cells/cm2 were seeded in 96-well plates and 
cultured for up to 28 days in medium as above supplemented with 100 µM NaF 
(Sigma) for the indicated time period. Otherwise cells received standard culture 
medium, which was exchanged 3 times per week.  
X-ray diffraction (XRD) of BG surfaces 
After 7, 14, or 28 days of culture, cells were removed and BG discs were 
rinsed in dH2O and air dried. Surfaces were then examined by XRD (X’Pert PRO 
MPD, PANalytical, Cambridge, UK; 40 kV/40 mA, CuKα, collected at room 
temperature) and analysed using X’Pert HighScore Plus software (v2.0, PANalytical, 
The Netherlands) and the International Centre for Diffraction Data database. 
Diffraction patterns were compared to reference patterns of hydroxycarbonate apatite 
(JCPDS 19-272) and fluorapatite (JCPDS 31-267).  
Scanning electron microscopy (SEM) to visualise cells and BG apatite formation 
After 7, 14 and 28 days in culture, some BG discs were rinsed with phosphate 
buffered saline (PBS) and fixed for 40 minutes in 2.5% (w/v) glutaraldehyde in 
sodium cacodylate buffer (pH 7.3) at 4 °C. Discs were then rinsed with PBS, 
dehydrated in a graded ethanol series, incubated with hexamethylsilasane (Sigma), 
sputter coated with gold and viewed on an FEI Inspect F SEM (FEI, Eindhoven, 
Netherlands) using the secondary electron mode at 10 kV. Other BG discs used for 
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cell culture analyses and XRD were also analysed by SEM to visualise apatite 
formation. Discs were sputter coating with gold/palladium and viewed in an SEM as 
above. 
Cell viability staining on BG discs 
Cell viability on BG discs was visualised after 14 and 28 days in culture by 
staining adherent cells using a Live/Dead® kit (Invitrogen). Live/Dead® utilises 
Calcein AM, which fluoresces green upon enzymatic conversion to calcein in live 
cells, and Ethidium Homodimer-1, which is excluded from live cells, but binds to 
nucleic acids in dead cells producing a red fluorescence. Cell-seeded BG discs were 
rinsed with PBS and transferred to a solution containing 1 μM Calcein AM and 1 μM 
Ethidium Homodimer-1 in PBS and incubated for 30 minutes, as previously described 
[29]. Cells were visualised under epifluorescent light and representative images were 
taken.  
Total cell quantification of cells cultured with BG 
The total number of cells attached to BG discs and in tissue culture plastic 
wells was determined by quantifying the activity of the ubiquitous cytosol enzyme, 
lactate dehydrogenase, using a CytoTox 96® Non-Radioactive Cytotoxicity Assay 
(Promega, Southampton, UK) as previously described [30, 31]. Briefly, cells were 
lysed in a 0.9% (v/v) solution of Triton X-100 (Sigma) in dH2O. The resulting lysate 
was then reacted with the kit’s substrate solution for 30 minutes. The reaction was 
stopped with the addition of 1M acetic acid and the resulting product was measured 
on a colorimetric plate reader at 490 nm.  
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Alkaline phosphatase (ALP) activity in cells cultured with BG 
ALP activity was measured by colorimetrically quantifying ALP’s conversion 
of p-nitrophenyl phosphate to p-nitrophenyl. At indicated time points, cultures were 
lysed in 0.9% (v/v) Triton X-100 in dH2O and reacted with a solution of 1 mg/mL p-
nitrophenyl phosphate in 0.1 M glycine buffer with 0.1 mM ZnCl2 and 0.1 mM MgCl2 
(pH = 10.4; all from Sigma). The reaction was stopped by adding 1 M NaOH and 
absorbance at 405 nm was measured on a colorimetric plate reader. 
AlamarBlue activity in cells treated with NaF 
AlamarBlue® (Invitrogen) activity, a measure of cell metabolic activity, was 
quantified in Saos-2 treated with NaF after 7, 14 and 28 days in culture according to 
the manufacturer’s instructions. Briefly, substrate solution was added to culture 
medium on live cells to create a 10% (v/v) solution and incubated for 1 h. The 
medium was then removed to an opaque 96-well plate and fluorescence was 
quantified at 560 nm excitation/590 nm emission.  
Total protein quantification to normalise ALP activity in cells treated with NaF 
ALP activity in NaF treated cultures was normalised to total protein content 
per well, which was determined using a BCA protein assay kit (Pierce, Thermo 
Scientific, UK) according to the manufacturer’s instructions. 
Interleukin-6 (IL-6) release from cells cultured with BG discs 
Release of IL-6 by Saos-2 cultured with BG discs for 7 and 14 days was 
quantified with a human IL-6 ELISA kit (R&D Systems, Abingdon, UK) according to 
the manufacturer’s instructions.  
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Statistical analyses 
Cell assay data from BG disc cultures are presented as means ± standard 
deviations and represent data from 8 individual discs. Assays on NaF-treated cultures 
are also presented as means ± standard deviations and represent 5 independent 
experiments with 6 replicates per experiment. The IL-6 ELISA was conducted with 3 
samples per condition. Comparisons of BG assay data were made using a one-way 
ANOVA with post-hoc Tukey test; NaF treatment results were compared with one-
way ANOVA and post-hoc LSD test. Significance is indicated when p < 0.05. 
Elemental analysis was carried out with at least 3 samples per condition. Fluoride 
concentration was determined from 3 samples per condition with the exception of at 
days 14 and 28 when low fluoride concentrations near the detection limit of the 
instrument rendered replicates superfluous.  
 
Results 
BG formation 
BG rods and discs were optically clear. Solid state nuclear magnetic resonance 
(NMR) spectroscopy previously demonstrated that BG silicate structure, consisting 
predominantly of Q2 chains, remained constant when adding CaF2 [26].  
Elemental analysis of ions released from BG 
The concentration of calcium in cell culture medium increased from its 
baseline of approximately 24 ppm to between 31 and 45 ppm after 2 days culture with 
all BG compositions (Table 2). Calcium concentration in all groups remained higher 
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than baseline for the entire 28-day culture period with the exception of the 13.62 and 
17.76 mol% CaF2 groups, for which calcium concentration was lower than baseline 
after 14 and 28 days in culture. Silicon release into cell culture media varied 
depending on BG composition. BG with 0 mol% CaF2 continued to release silicon at 
levels between ~ 20 and 50 ppm throughout the culture period. In contrast, by later 
time points, the 13.62 and 17.76 mol% CaF2 groups released little to no silicon.  
Fluoride release was dependent on fluoride concentration in BG, as 
compositions with higher fluoride contents gave higher fluoride concentrations in the 
culture medium (Table 3). The majority of fluoride, however, was released during the 
pre-conditioning period and the first week in culture. Indeed, after 14 days incubation 
of the BGs in culture medium, the fluoride concentration was less than 1 ppm.  
X-ray diffraction (XRD) of BG surfaces 
XRD patterns demonstrate the time- and composition-dependent formation of 
crystalline phases on the surface of BG discs whilst in cell culture media. Diffraction 
patterns obtained from the 0 mol% CaF2 group revealed an amorphous halo and 
lacked sharp peaks indicative of crystalline material at all time points examined 
(Figure 1). The 1.00 and 4.75 mol% CaF2 groups showed no distinct peaks after 7 
days, but rather produced a shift in the amorphous halo position. A single reflection at 
29.5 °2θ for the 4.75 mol% group was observed after 7 days in culture indicating the 
formation of the calcite form of calcium carbonate (JCPDS 5-586). However, after 14 
and 28 days, typical apatitic features at 26 and 32-34 °2θ were observed. All other BG 
groups showed peaks indicative of apatite at all the time points examined.  
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Scanning electron microscopy (SEM) to visualise cells and BG apatite formation 
Representative SEM images of Saos-2 cells attached to BG discs show 
morphologically normal cells attached to the material surface (Figure 2a, b, and c). 
SEM images further demonstrate the presence of structures typical of apatite on BG 
surfaces after 7, 14 and 28 days in culture. At all time points, the 0 mol% CaF2 group 
showed very few apatite-like formations (Figure 2d, e, and f). All other compositions 
were notable for apatite-like structures on their surfaces, as indicated by the presence 
of typical agglomerates of small needle-like crystals (representative images, Figure 
2g-l).  
Cell viability staining on BG discs 
Fluorescence staining of live and dead cells on BG discs revealed remarkable 
differences in cell attachment, morphology and proliferation that were BG 
composition dependent (Figure 3). On 0 mol% CaF2 discs, we observed limited cell 
attachment and proliferation. The addition of 1.00 mol% CaF2, however, promoted 
increased cell proliferation, particularly at later time points, as a nearly confluent cell 
layer was evident after 28 days. Furthermore, after 28 days in culture, cellular 
aggregates were evident on compositions with 9.28 mol% CaF2 and higher.  
Total cell quantification of cells cultured with BG 
Saos-2 attachment and proliferation varied depending on BG composition. 
After 14 days in culture, significantly more cells were attached to 1.00 mol% CaF2 
BG discs than 0, 9.28, 13.62 or 17.76 mol% CaF2 compositions (Figure 4a). 
Similarly, 4.75 mol% CaF2 discs had significantly more cells than either 9.28 or 
17.76. This same trend held after 28 days in culture. Whilst cells continued to 
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proliferate on all BG compositions, 1.00 mol% CaF2 discs had significantly more 
adherent cells than any other group. The 4.75 mol% CaF2 group also supported 
significantly more cells than either the 0 or 9.28 mol% CaF2 compositions.  
When the number of cells adherent to tissue culture plastic in wells containing 
BG discs (and thus exposed to their dissolution ions) was examined, a different trend 
was observed. After 14 days in culture, significantly more cells were observed in 
wells with 4.75 mol% CaF2 discs when compared to all other groups at the same time 
point (Figure 4b). Furthermore, more cells were observed in cultures exposed to 1.00 
and 9.28 mol% CaF2 BG discs when compared to either 13.62 or 17.76. By day 28, 
there were significantly more cells in wells exposed to 4.75 mol% BG than any other 
group. Significantly fewer cells were observed in wells exposed to the 0 mol% CaF2 
BG discs when compared to all other groups.  
Alkaline phosphatase (ALP) activity in cells cultured with BG 
ALP activity in Saos-2 cultured on BG discs increased with increasing BG 
fluoride content. After 14 days in culture, cells on 17.76 mol% CaF2 discs produced 
significantly higher ALP activity per cell than those on 0 mol% CaF2 BG discs 
(Figure 5a). Similarly, after 28 days in culture, cells on 13.62 and 17.76 mol% CaF2 
produced significantly higher ALP activity than those on 0 mol% discs at the same 
time point. In cells exposed to the dissolution products of BG discs, but not in direct 
contact, a similar trend was observed whereby after 14 and 28 days in culture, cells in 
wells containing 17.76 mol% CaF2 BG discs had significantly higher ALP activity 
than all other groups at the same time point (Figure 5b). Interestingly, after 14 and 28 
days in culture, cells in wells containing 1.00 mol% CaF2 BG discs also showed 
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increased ALP activity, which was significantly higher than that detected in 0, 4.75 or 
9.28 mol% CaF2 groups. 
Interleukin-6 (IL-6) release from cells cultured with BG discs 
IL-6 release from cells cultured with BG discs was higher in groups with 
higher BG fluoride content. Indeed, the amount of IL-6 released per cell after 7 days 
from Saos-2 cultured with 17.76 mol% CaF2 was significantly greater than that 
detected from cells cultured with any other BG composition. After 14 days, Saos-2 
cultured with both the 17.76 and 13.62 mol% CaF2 discs released significantly more 
IL-6 than those cultured with 1.00 or 4.75 mol% CaF2 BG. 
Metabolic and ALP activity in NaF-treated cultures 
In cultures treated with NaF, early exposure to fluoride more strongly 
upregulated Saos-2 metabolic and ALP activity compared to long-term or late 
exposure. That is, after 14 days in culture, AlamarBlue® activity was significantly 
higher in cultures treated with NaF for the first 24 hours when compared to cultures 
treated from days 0-7, 0-14 or 7-14 (Figure 7a). Similarly, after 28 days in culture, 
ALP activity per mg of protein was significantly higher in cultures treated with NaF 
for the first 24 hours when compared to those treated from days 0-7, 0-14, 0-28, 7-14 
or 14-28 (Figure 7b).  
 
Discussion 
We analysed the effects of a series of fluoride-containing BG on human 
osteoblasts in vitro. We cultured cells directly in contact with BG, whose dynamic 
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surface is thought to affect cell attachment and proliferation, and on tissue culture 
plastic in the same well as BG discs so that they were exposed to the dissolved ions 
released from the BG. Elemental analyses of culture media samples collected 
throughout revealed how BG composition affected ion release and thus the level of 
exposure experienced by cells.  
Silicon, which comprises a large proportion of BG by both weight and molar 
content, is thought to affect bone mineralisation as animals fed silicon-deficient diets 
suffer from severe skeletal abnormalities [32]. All of the BG compositions studied 
here released silicon, particularly over the first week of culture. The continued release 
of silicon by the 0 mol% group at later time points, however, suggests that the BG 
continued to dissolve over the entire 28-day period. This was confirmed by XRD and 
SEM analyses of BG surfaces, which demonstrated that this composition never 
formed a detectable apatite layer. Conversely, low silicon release in the high fluoride 
compositions reflects the formation of apatite on their surfaces, which is sparingly 
soluble, and likely prevented further dissolution and continued silicon release. 
Furthermore, levels of calcium lower than that in standard culture medium were 
measured in cultures with high fluoride-content BG after 14 and 28 days. This 
suggests that calcium was being removed from the medium and contributing to the 
formation of apatite on the BG surface. This was confirmed by XRD and SEM results 
which both demonstrated the formation of apatite on the surface of these 
compositions.  
We also detected very little fluoride in culture medium at later time points, 
which can also be explained by the formation of apatite on the surface of BG. 
Fluorapatite is resistant to acid degradation and dissolution (indeed, more so than 
hydroxyapatite), which likely prevented further degradation of BG once an initial 
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fluorapatite layer was formed. Whilst this may seem a disadvantage of fluoride-
containing BG systems, our data with NaF-treated cultures suggest that early release 
of fluoride may be the most efficacious means to deliver beneficial levels of ions. 
Indeed, when we treated Saos-2 cultures with NaF, an initial 24-hour exposure 
elicited significant increases in osteoblast metabolic activity after 14 days in culture, 
and ALP activity after 28 days when compared to either continuous treatment or 
treatment at later time points. This is in keeping with previous studies which have 
suggested that the effects of fluoride are stronger on osteoblast precursors as opposed 
to more mature cells [22]. Furthermore, although the continuous delivery of 
therapeutic ions via a biomaterial may appear advantageous, excessive release can 
cause adverse effects. Excess fluoride can cause skeletal fluorosis, damaging bone 
structure and decreasing its strength. And indeed, caution should be exercised in 
general when substituting reportedly therapeutic ions into BG. Although zinc, for 
example, plays a number of essential biological roles in the body, particularly in bone 
formation, toxicity can result if released levels are too high [33].  
Interestingly, the levels of ions detected in cell culture media after up to 28 
days exposure to BG differed markedly from those observed in our previous studies in 
which an identical BG series was soaked in Tris buffer or simulated body fluid 
(SBF)[26, 34].  This suggests that the precise composition of the solutions BG are 
exposed to plays an important role in BG ion release and should be considered when 
in vitro studies are applied to biological systems. 
The crystalline phases formed on the surfaces of the BG examined here were 
apatite like. They may correspond to hydroxyapatite, fluorapatite or a mixed 
fluorohydroxyapatite (although XRD cannot distinguish between them). Our previous 
examinations of these BG with 19F solid state NMR have shown that a fluoridated 
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apatite is present in BG containing fluoride [34, 35], however, we found no indication 
of a fluorite crystal phase (CaF2) for any composition at any time point examined 
here. This is in contrast to our previous work which demonstrated that when the same 
BG were incubated in SBF or Tris buffer, they formed a combination of fluorapatite 
and fluorite, with a greater proportion of fluorite in BG with higher fluoride contents 
[34, 36]. Our findings here are most likely due to the relatively high levels of 
phosphorus in RPMI 1640 culture medium (174 ppm) compared to SBF (31 ppm) or 
Tris buffer (0ppm), which favours fluorapatite formation over fluorite. These 
observations also demonstrate the limitations of SBF testing, as experiments with cell 
culture medium, which are more regularly exchanged, may provide a more in vivo-
like model to examine how bodily fluids will interact with BG surfaces. 
Cell culture experiments demonstrated clear effects of BG composition on cell 
attachment, proliferation, and ALP activity. These effects were also dependent on 
whether the cells were in direct contact with the BG or just exposed to their 
dissolution ions. Total cell quantification experiments revealed that 1.00 mol% CaF2 
BG supported significantly greater numbers of cells than any other group, however, 
the cells proliferated as a monolayer and failed to form aggregates, often referred to as 
‘bone nodules’. This suggests that the formation of a surface apatite layer strongly 
promoted cell attachment and proliferation, but signals for differentiation, were 
lacking. Conversely, very few cells adhered to or proliferated on 0 mol% CaF2 BG. 
The lack of crystalline peaks in the XRD pattern for the 0 mol% CaF2 BG confirms 
that this composition never formed detectable amounts of an apatite-like phase on its 
surface. The nanocrystalline apatite formed on BG is thought to promote protein 
adsorption and thus aid in cell attachment [37]. In BG with higher fluoride contents, 
whilst cell attachment to BG surfaces was low by comparison with the 1.00 mol% 
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CaF2 group, cells formed dense aggregates, as were evident in fluorescence 
microscopy images, and had significantly higher ALP activity than those on lower 
fluoride content BG. Osteoblasts are known to form mineralising nodules in culture as 
part of the differentiation process [38]. Although we did not examine cellular 
aggregates for mineral formation, the presence of nodular structures and increased 
ALP activity suggest that either cell interactions with the apatite surface or ions 
released from the high fluoride-content BG promoted cell differentiation. 
The effects of fluoride-containing BG on the proliferation and differentiation 
of cells only exposed to their dissolution ions, however, were not as straightforward. 
That is, whilst ALP activity per cell was highest in groups exposed to the dissolution 
ions of BG with the highest fluoride contents, cell proliferation was highest in the 
4.75 mol% CaF2 group. This result appears counterintuitive as fluoride has been 
shown to enhance osteoblast proliferation [19]. Nevertheless, calcium has also been 
shown to play a role in osteoblast proliferation, but with an inverse effect [39]. 
Calcium, which was most likely lost from solution as a result of precipitation 
reactions on the BG surface, was lowest in the highest fluoride BG groups, which 
suggests that the combination of fluoride and calcium ions in this more intermediate 
group promoted cell proliferation to the greatest extent. Lower proliferation in the 
higher fluoride-containing groups could also arise from toxicity as Bergandi et al. 
have demonstrated oxidative stress-dependent toxicity associated with osteoblast 
exposure to fluoride and fluoride-containing bioactive glasses [40].  Nevertheless, 
fluoride-mediated toxicity appears to be cell line dependent [41-43] and could arise 
from differences in culture techniques (particulate versus monolith bioactive glass 
[40]).  Furthermore, studies reporting the level at which fluoride produces a cytotoxic 
effect are conflicting [41].  
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Interleukin-6 (IL-6) is a multifunctional cytokine involved in a range of pro- 
and anti-inflammatory processes. In bone, IL-6 is produced by osteoblasts where it 
acts to stimulate osteoclast differentiation and promote bone resorption [44]. 
Nevertheless, IL-6 levels are reduced in post-menopausal women and significantly 
correlated with bone loss [45]. Furthermore, osteoporotic patients treated with PTH 
show elevated serum levels of IL-6 [46]. Indeed, fracture healing and bone 
mineralisation is delayed in IL-6 knockout mice when compared to wild-type controls 
[47]. Together these data suggest that whilst IL-6 promotes osteoclast activity and 
bone resorption, it is a marker for bone formation. Here, our data show increased IL-6 
secretion per cell with increased fluoride content in the BG. This is in keeping with 
reports of increased IL-6 secretion from osteoblasts in patients treated with PTH [48, 
49], and suggests that fluoride-containing BG may promote a similar bone formation 
response.  
 
Conclusions 
In summary, we have shown that fluoride-containing BG, which have the 
ability to release fluoride locally at an implant site, affect osteoblast cells in vitro, 
promoting osteoblast differentiation and stimulating markers for bone formation. 
These effects may make them good candidates for a range of bone regeneration 
applications.  
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Figure Captions 
Figure 1: X-ray diffraction patterns between 18 and 60 °2θ collected from the surface of BG discs 
incubated in cell culture medium for a) 7, b) 14 and c) 28 days.  Labels indicate apatite (Ap) and calcium 
carbonate (C). 
Figure 2: Representative scanning electron microscopy images of cells adherent to BG discs containing 
a) 1.00, b) 9.28, and c) 17.76 mol% CaF2 after 14 days in culture.  Scale bars represent 50 µm, 30 µm, 
and 50 µm, respectively. d-l) Representative images of apatite formation on BG discs of selected 
compositions after 7, 14 and 28 days in culture. All other groups formed apatite on their surfaces similar 
to that noted in the 13.62 mol% CaF2 group. Cracks in the underlying apatite layer resulted from sample 
dehydration. Scale bars represent 3 µm. 
Figure 3: Cell viability staining of Saos-2 cells adherent to BG discs after 14 and 28 days in culture. Live 
cells appear green whilst dead cells are stained red. Scale bar = 500 µm.  
Figure 4: a) Total number of Saos-2 adherent to BG discs after 7, 14 and 28 days in culture.* indicates 
significantly more cells in the indicated group compared to the 0 mol% CaF2 group at the same time 
point. † significantly more cells than the 9.28 mol% CaF2 group at the same time point. # significantly 
more cells than 13.62 mol% CaF2 group at same time point. § significantly more cells than 17.76 mol% 
CaF2 group at same time point. b) Total number of Saos-2 cells in cultures exposed to the dissolution 
products of BG discs for up to 28 days. * indicates significantly more cells in the indicated group 
compared to any other group at the same time point. † significantly fewer cells than any other group at 
the same time point. # significantly more cells than 13.62 mol% CaF2 group at same time point. § 
significantly more cells than 17.76 mol% CaF2 group at same time point. 
Figure 5: a) Alkaline phosphatase activity of Saos-2 cells cultured on the surface of BG discs for 7, 14 
and 28 days. * indicates significantly higher ALP activity per cell in the indicated group compared to 
Saos-2 on 0 mol% CaF2 discs at the same time point. b) Alkaline phosphatase activity of Saos-2 cells 
exposed to the dissolution products of BG discs after 7, 14 and 28 days in culture. * significantly higher 
ALP activity compared to all other groups at the same time point. + significantly higher ALP activity than 
the 0 mol% CaF2 group at same time point. ‡ significantly higher ALP activity than the 4.75 mol% CaF2 
group at same time point. † significantly higher ALP activity than 9.28 mol% CaF2 group at same time 
point. # significantly higher ALP activity than 13.62 mol% CaF2 group at the same time point. 
Figure 6: Release of IL-6 from Saos-2 cultured with BG discs. * significantly higher levels of IL-6 were 
detected in the indicated group compared to all other groups at the same time point. & significantly 
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higher levels compared to the 1.00 mol% CaF2 group at the same time point; ‡ significant compared to 
4.75 mol% CaF2 group at the same time point; † significant compared to 9.28 mol% CaF2 group at the 
same time point.  
Figure 7: a) AlamarBlue® activity after 7, 14 and 28 days in culture in Saos-2 treated with NaF for the 
indicated time periods. b) Alkaline phosphatase activity per mg protein after 7, 14 and 28 days in culture 
for Saos-2 treated with NaF for the indicated time periods. * significantly higher levels in the indicated 
group at the same time point compared to cultures treated for days 0-7. † significant compared to 
cultures treated for days 0-14. ‡ compared to cultures treated for days 7-14. # compared to cultures 
treated for days 0-28. § compared to cultures treated for days 14-28. 
 
Table Captions 
Table 1: BG compositions in mole percent. 
Table 2: Elemental concentrations in ppm of calcium and silicon in cell culture medium over the 28 day 
culture period (n=3). 
Table 3: Fluoride concentrations in cell culture medium during pre-conditioning and over the 28 day 
culture period (n=3; except at days 14 and 28, n=1). 
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CaF2 SiO2 P2O5 CaO Na2O 
     
0 49.47 1.07 23.08 26.38 
1.00 48.98 1.06 22.85 26.12 
4.75 47.12 1.02 21.98 25.13 
9.28 44.88 0.97 20.94 23.93 
13.62 42.73 0.92 19.94 22.79 
17.76 40.68 0.88 18.98 21.69 
Table 1: BG compositions in mole percent. 
[Ca] (ppm) 
  
DAY 
   
       
 
         mol% CaF2 0 2 4 7 14 28 
        
 
0 24.08 32.22 30.36 42.36 37.45 53.08 
 
1 24.08 38.99 45.11 55.06 23.93 24.28 
 
4.75 24.08 31.72 43.62 59.37 51.77 31.98 
 
9.28 24.08 36.26 45.34 66.64 48.01 12.63 
 
13.62 24.08 44.67 56.95 39.87 4.43 11.07 
 
17.76 24.08 43.65 47.51 23.14 5.58 13.58 
        [Si] (ppm) 
   
DAY 
   
        
 
      mol% CaF2 0 2 4 7 14 28 
        
 
0 0.15 22.72 23.94 27.07 35.21 50.26 
 
1 0.15 34.45 43.92 37.67 40.21 1.53 
 
4.75 0.15 1.52 1.08 1.38 2.97 7.67 
 
9.28 0.15 2.05 6.74 3.31 27.13 8.06 
 
13.62 0.15 17.85 14.72 30.33 4.32 0.23 
 
17.76 0.15 29.94 30.06 54.36 4.87 0.52 
 
 
Table 2: Elemental concentrations in ppm of calcium and silicon in cell culture medium over the 28 
day culture period (n=3). 
[F] (ppm) 
 
Pre-conditioning 
  
DAY 
 
     
 
 
    mol% CaF2 -4 -3 -2 -1 1 3 5 7 14 28 
            
 
1 2.78 1.55 2.53 2.32 1.73 1.56 1.14 0.63 0.39 0.29 
 
4.75 5.77 1.65 1.91 1.76 1.46 0.95 0.94 0.73 0.53 0.28 
 
9.28 11.96 3.26 3.32 3.14 2.32 2.57 3.87 5.18 0.49 0.34 
 
13.62 15.86 10.66 20.01 25.97 19.92 33.76 5.90 3.04 0.64 0.27 
 
17.76 16.43 16.92 30.25 50.08 17.80 9.18 4.18 1.70 0.51 0.30 
 
Table 3: Fluoride concentrations in cell culture medium during pre-conditioning and over the 28 day culture period (n=3; except at days 14 and 28, n=1). 
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